Literature DB >> 12515774

Weighing the risks and benefits of tamoxifen.

Michelle Greiver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12515774      PMCID： PMC139303     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

Review 1.  Tamoxifen for breast cancer prevention: safety warning.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

2.  Postmenopausal hormone replacement therapy for chronic disease prevention: results from the Women's Health Initiative trial.

Authors:  Donald Farquhar
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

Review 3.  Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Authors:  M H Gail; J P Costantino; J Bryant; R Croyle; L Freedman; K Helzlsouer; V Vogel
Journal:  J Natl Cancer Inst       Date:  1999-11-03       Impact factor: 13.506

4.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.